Polygenic Embryo Screening: High Approval Despite Substantial Concerns from the U.S. Public
Preprint
Abstract
Polygenic embryo screening (PES) is a novel – yet commercially available – technology that can compute genetic likelihood estimates of polygenic conditions (e.g., diabetes, depression) and traits (e.g., height, cognitive ability) in embryos. Patients undergoing in vitro fertilization (IVF) can use these polygenic scores to select which embryos to transfer for implantation with the goal of having a child. We conducted a survey of the U.S. public to examine attitudes toward PES encompassing acceptance, interest, potential uses, and concerns (n=1435). Our results indicate 72% public approval for PES, with 82% expressing some interest in using PES if already undergoing IVF. Approval for using PES for embryo selection is notably high for physical health (77%) and psychiatric conditions (72%). In contrast, there is minority approval for embryo selection based on PES for behavioral traits (36%) and physical traits (30%). Nevertheless, concerns about PES leading to false expectations, eugenic practices, and stigma are pronounced (54-55% find them “very” to “extremely” concerning). In a second sample of participants (n=192), presenting concerns at survey onset (vs. end) reduced approval (−28%) by mostly increasing ambivalence (+24%), and only slightly increasing disapproval (+4%). Given its commercial availability, practical limitations, and ethical concerns among physicians, patients, geneticists, bioethicists, and legal scholars, it is notable that there is such high public approval and interest in using PES. Understanding these attitudes is essential for informing policymakers, healthcare professionals, and researchers about the public’s perspectives on this novel biotechnology and debate about the role of medicine in regulating the use of PES.Keywords
This publication has 38 references indexed in Scilit:
- Who Should Regulate Preimplantation Genetic Diagnosis in the United States?AMA Journal of Ethics, 2018
- Current clinical use of polygenic scores will risk exacerbating health disparitiesbioRxiv, 2018
- Meta-analysis of genome-wide association studies for height and body mass index in ∼700000 individuals of European ancestryHuman Molecular Genetics, 2018
- The nature of nurture: Effects of parental genotypesScience, 2018
- Type 1 diabetes genome‐wide association studies: not to be lost in translationClinical & Translational Immunology, 2017
- Meta-analysis of Genome-Wide Association Studies for Extraversion: Findings from the Genetics of Personality ConsortiumBehavior Genetics, 2015
- Genetics of skin color variation in Europeans: genome-wide association studies with functional follow-upHuman Genetics, 2015
- Ascertainment Biases in SNP Chips Affect Measures of Population DivergenceMolecular Biology and Evolution, 2010
- Coronary Heart Disease Risk Prediction in the Era of Genome-Wide Association StudiesCirculation, 2010
- Population stratification and spurious allelic associationThe Lancet, 2003